Arkolith/Insider Trading/COLL/Form 4

Freund John Gordon

DirectorCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed Aug 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$401K
Net Open-Market Flow
-$401K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2025Sell(S)12K$34.36$401K23K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-014202) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML